Best Practice & Research Clinical Obstetrics & Gynaecology

Papers
(The TQCC of Best Practice & Research Clinical Obstetrics & Gynaecology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Primary HPV screening for cervical cancer98
The impact of advanced maternal age on pregnancy outcome96
Advanced maternal age and adverse pregnancy outcomes92
Breast cancer prevention in high-risk women84
Fertility preservation in women for medical and social reasons: Oocytes vs ovarian tissue75
Transforming intrapartum care: Respectful maternity care66
Ovarian cancer screening: Current status and future directions65
Preterm birth prevention58
Pain management during labor and vaginal birth58
A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders56
HPV vaccination and cancer prevention52
Long-acting reversible contraceptive (LARCs) methods50
Progesterone and endometrial cancer48
Risk-based breast cancer screening strategies in women47
The epidemiology of endometriosis is poorly known as the pathophysiology and diagnosis are unclear46
Improving access to and use of contraception by adolescents: What progress has been made, what lessons have been learnt, and what are the implications for action?45
Menopause transition: Physiology and symptoms44
The historical aspects of vaccination in pregnancy44
Vaccines - safety in pregnancy43
Endometrial cancer prevention in high-risk women43
Uptake of vaccination in pregnancy40
Current and future approaches to screening for endometrial cancer38
Effects of the COVID pandemic on pregnancy outcomes38
Maternal morbidity and mortality due to placenta accreta spectrum disorders36
Assisted conception in women of advanced maternal age33
Male and female condoms: Their key role in pregnancy and STI/HIV prevention33
Sporadic pregnancy loss and recurrent miscarriage31
Progesterone and abnormal uterine bleeding/menstrual disorders30
Hormone replacement therapy – Current recommendations30
Fertility awareness-based methods of family planning30
Population-based genetic testing for Women's cancer prevention27
The pharmacodynamics and safety of progesterone26
Progesterone use in assisted reproductive technology25
Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers25
Clinical presentation and diagnosis of Gestational Trophoblastic Disease23
Hepatitis B – Vertical transmission and the prevention of mother-to-child transmission23
Overcoming barriers to breastfeeding23
Genetics of gestational trophoblastic disease22
Overview of modern contraception21
Classification of deep endometriosis (DE) including bowel endometriosis: From r-ASRM to #Enzian-classification21
Immunology and the immunological response in pregnancy21
Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities21
Advances in the medical management of bowel endometriosis20
Reduction of multiple pregnancy: Counselling and techniques20
MRI of intestinal endometriosis19
Progesterone, reproduction, and psychiatric illness18
Breast cancer management in 2021: A primer for the obstetrics and gynecology18
Antenatal diagnosis of placenta accreta spectrum (PAS) disorders18
Non-invasive prenatal testing in the context of IVF and PGT-A18
Post pregnancy contraception18
Treatment of low-risk gestational trophoblastic neoplasia17
Pathology of gestational trophoblastic disease (GTD)17
Cognition and mental health in menopause: A review17
Adjuvant and post-surgical treatment in endometrial cancer17
Premature ovarian insufficiency16
Progesterone: History, facts, and artifacts16
The future of electronic fetal monitoring16
Breast cancer screening in low and middle-income countries16
Genetic testing for epithelial ovarian cancer16
Deep endometriosis: The place of laparoscopic shaving15
Etiopathogenesis and risk factors for placental accreta spectrum disorders14
Environmental toxicants and male fertility14
Vaccination in pregnancy: Challenges and evidence-based solutions14
Ovarian transposition and cervical cancer14
How to set up a regional specialist referral service for Placenta Accreta Spectrum (PAS) disorders?14
Ultrasonography for bowel endometriosis14
Use of the partograph - Current thinking13
Pregnancy outcomes following oocyte donation13
Placental site trophoblastic tumour and epithelioid trophoblastic tumour13
Obesity and menopause13
Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease13
A review of fertility preservation in patients with breast cancer13
Progesterone and breast13
Hepatitis B – chronic carrier status and pregnancy outcomes: An obstetric perspective12
Drug-induced liver injury in pregnancy12
Desire for children and fertility preservation in transgender and gender-diverse people: A systematic review12
Robotic treatment of bowel endometriosis12
Management of viral hepatitis A, C, D and E in pregnancy12
Menopause review: Emerging treatments for menopausal symptoms11
Autoimmune hepatitis and pregnancy11
Bowel resection for intestinal endometriosis11
Self-care provision of contraception: Evidence and insights from contraceptive injectable self-administration11
The epidemiology of obesity in reproduction11
Breast cancer screening in average and high-risk women11
Progesterone and fetal-neonatal neuroprotection11
Induction of labour in low-risk pregnancies before 40 weeks of gestation: A systematic review and meta-analysis of randomized trials10
Translational and pharmacological principles of hyperthermic intraperitoneal chemotherapy for ovarian cancer10
Progression of the first stage of spontaneous labour10
Association between the number of oocytes and cumulative live birth rate: A systematic review10
Inflammatory diseases of the breast10
Ovarian tissue and oocyte cryopreservation prior to iatrogenic premature ovarian insufficiency10
The initiation of labour at term gestation: Physiology and practice implications10
Adjuvant treatment in cervical, vaginal and vulvar cancer10
The vanishing twin: Diagnosis and implications10
Surgery including fertility-sparing treatment of GTD10
Augmentation of labour9
Alternative and non-hormonal treatments to symptoms of menopause9
Management of breast complaints and high-risk lesions9
Reorganisation of obstetric services during the COVID pandemic – Experience from National Maternity Hospital Dublin Ireland9
Conservative approach: Intentional retention of the placenta9
The opioid epidemic9
Pregnancy-specific liver diseases9
How and when to recommend delivery of a growth-restricted fetus: A review9
Male infertility and gonadotropin treatment: What can we learn from real-world data?9
Cancer genetics and breast cancer9
Placenta accreta spectrum disorders - Peri-operative management: The role of the anaesthetist9
Role of interventional radiology in placenta accreta spectrum (PAS) disorders9
COVID-19 in Women's health: Epidemiology9
Adjuvant and post-surgical treatment in high-grade epithelial ovarian cancer9
Lessons learned from the A (H1N1) influenza pandemic9
Morbidity after local excision of the transformation zone for cervical intra-epithelial neoplasia and early cervical cancer9
Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo 8
Psychological aspects and fertility issues of GTD8
Future vaccines in pregnancy8
Twin reverse arterial perfusion: Timing of intervention8
Pathogenesis of bowel endometriosis8
Effects of endocrine disrupting compounds on female fertility8
Management of abnormal invasive placenta in a low- and medium-resource setting8
Role of adjuvant and post-surgical treatment in gynaecological cancer8
The second stage of labor8
0.026379823684692